These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33468668)

  • 41. In cellulo analyses of the p.Val322Ala mutation on the CFTR protein conformation and activity.
    Farhat R; El-Seedy A; Sari AIP; Norez C; Pasquet MC; Becq F; Kitzis A; Ladevèze V
    C R Biol; 2017 Aug; 340(8):367-371. PubMed ID: 28784578
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The CFTR frameshift mutation 3905insT and its effect at transcript and protein level.
    Sanz J; von Känel T; Schneider M; Steiner B; Schaller A; Gallati S
    Eur J Hum Genet; 2010 Feb; 18(2):212-7. PubMed ID: 19724303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reporting Two Novel Mutations in Two Iranian Families with Cystic Fibrosis, Molecular and Bioinformatic Analysis.
    Hosseini Nami A; Kabiri M; Zeinali S
    Iran Biomed J; 2022 Nov; 26(5):398-405. PubMed ID: 35468710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
    Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
    Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of ENaC and CFTR mutations may predispose to cystic fibrosis-like disease.
    Fajac I; Viel M; Gaitch N; Hubert D; Bienvenu T
    Eur Respir J; 2009 Sep; 34(3):772-3. PubMed ID: 19720813
    [No Abstract]   [Full Text] [Related]  

  • 46. Deletion of CFTR translation start site reveals functional isoforms of the protein in CF patients.
    Ramalho AS; Lewandowska MA; Farinha CM; Mendes F; Gonçalves J; Barreto C; Harris A; Amaral MD
    Cell Physiol Biochem; 2009; 24(5-6):335-46. PubMed ID: 19910674
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spectrum of Cystic Fibrosis Conductance Regulator Gene Mutations Reported in Pakistani Descent Cystic Fibrosis Patients.
    Majid H; Khan AH; Hashmi SB; Moatter T; Nasir A
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):1042-1046. PubMed ID: 35932130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characterization of 19 disease-associated missense mutations in the regulatory domain of the cystic fibrosis transmembrane conductance regulator.
    Vankeerberghen A; Wei L; Jaspers M; Cassiman JJ; Nilius B; Cuppens H
    Hum Mol Genet; 1998 Oct; 7(11):1761-9. PubMed ID: 9736778
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spectrum of mutations in the CFTR gene of patients with classical and atypical forms of cystic fibrosis from southwestern Sweden: identification of 12 novel mutations.
    Strandvik B; Björck E; Fallström M; Gronowitz E; Thountzouris J; Lindblad A; Markiewicz D; Wahlström J; Tsui LC; Zielenski J
    Genet Test; 2001; 5(3):235-42. PubMed ID: 11788090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Spectrum of CFTR mutations in Chechen cystic fibrosis patients: high frequency of c.1545_1546delTA (p.Tyr515X; 1677delTA) and c.274G>A (p.Glu92Lys, E92K) mutations in North Caucasus.
    Petrova NV; Kashirskaya NY; Saydaeva DK; Polyakov AV; Adyan TA; Simonova OI; Gorinova YV; Kondratyeva EI; Sherman VD; Novoselova OG; Vasilyeva TA; Marakhonov AV; Macek M; Ginter EK; Zinchenko RA
    BMC Med Genet; 2019 Mar; 20(1):44. PubMed ID: 30898088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heterogeneous spectrum of CFTR gene mutations in Korean patients with cystic fibrosis.
    Jung H; Ki CS; Koh WJ; Ahn KM; Lee SI; Kim JH; Ko JS; Seo JK; Cha SI; Lee ES; Kim JW
    Korean J Lab Med; 2011 Jul; 31(3):219-24. PubMed ID: 21779199
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A-->G, 2751+2T-->A, 296+1G-->C, 1717-9T-->C-D565G) and one nonsense mutation (E822X) in the CFTR gene.
    Tzetis M; Efthymiadou A; Doudounakis S; Kanavakis E
    Hum Genet; 2001 Dec; 109(6):592-601. PubMed ID: 11810271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Application of multiplex ARMS and SSCP/HD analysis in molecular diagnosis of cystic fibrosis in Indian patients.
    Ashavaid TF; Kondkar AA; Dherai AJ; Raghavan R; Udani SV; Udwadia ZF; Desai D
    Mol Diagn; 2005; 9(2):59-66. PubMed ID: 16137181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. From CFTR biology toward combinatorial pharmacotherapy: expanded classification of cystic fibrosis mutations.
    Veit G; Avramescu RG; Chiang AN; Houck SA; Cai Z; Peters KW; Hong JS; Pollard HB; Guggino WB; Balch WE; Skach WR; Cutting GR; Frizzell RA; Sheppard DN; Cyr DM; Sorscher EJ; Brodsky JL; Lukacs GL
    Mol Biol Cell; 2016 Feb; 27(3):424-33. PubMed ID: 26823392
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synonymous codon usage affects the expression of wild type and F508del CFTR.
    Shah K; Cheng Y; Hahn B; Bridges R; Bradbury NA; Mueller DM
    J Mol Biol; 2015 Mar; 427(6 Pt B):1464-1479. PubMed ID: 25676312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. R248G cystic fibrosis transmembrane conductance regulator mutation in three siblings presenting with recurrent acute pancreatitis and reproductive issues: a case series.
    Villalona S; Glover-López G; Ortega-García JA; Moya-Quiles R; Mondejar-López P; Martínez-Romero MC; Rigabert-Montiel M; Pastor-Vivero MD; Sánchez-Solís M
    J Med Case Rep; 2017 Feb; 11(1):42. PubMed ID: 28196530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation.
    Pissarra LS; Farinha CM; Xu Z; Schmidt A; Thibodeau PH; Cai Z; Thomas PJ; Sheppard DN; Amaral MD
    Chem Biol; 2008 Jan; 15(1):62-9. PubMed ID: 18215773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation.
    Sermet-Gaudelus I; Vallée B; Urbin I; Torossi T; Marianovski R; Fajac A; Feuillet MN; Bresson JL; Lenoir G; Bernaudin JF; Edelman A
    Pediatr Res; 2002 Nov; 52(5):628-35. PubMed ID: 12409506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting Nonsense: Optimization of 1,2,4-Oxadiazole TRIDs to Rescue CFTR Expression and Functionality in Cystic Fibrosis Cell Model Systems.
    Pibiri I; Melfi R; Tutone M; Di Leonardo A; Pace A; Lentini L
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899265
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Two CFTR mutations within codon 970 differently impact on the chloride channel functionality.
    Amato F; Scudieri P; Musante I; Tomati V; Caci E; Comegna M; Maietta S; Manzoni F; Di Lullo AM; De Wachter E; Vanderhelst E; Terlizzi V; Braggion C; Castaldo G; Galietta LJV
    Hum Mutat; 2019 Jun; 40(6):742-748. PubMed ID: 30851139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.